搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
trade it to $30
Alector, Inc.
(
NASDAQ:ALEC
)
KhanhC.Hoang
NASDAQ:ALEC
Alector, Inc.
Fibonacci
1
0
fibonacci
The safety data is favorable and biomarker/clinical data of AL001 (latozinemab) is supportive of activity in this expanded group of patients. Today's data also suggests the potential for a treatment effect in other TDP pathologies (such as ALS).
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。